New Monoclonal Antibody Shows Promise in Rapidly Reducing Dengue Virus

A human clinical trial evaluating the monoclonal antibody Dengue-mAb, also known as VIS513, demonstrated a rapid reduction in infectious dengue virus levels in adult patients, according to findings published in ... Read more